2000 Fiscal Year Final Research Report Summary
ヒト癌におけるP16-COK-Rb細胞回転異常に関する病理学的研究
| Project/Area Number |
11470049
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B).
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Human pathology
|
|---|
| Research Institution | Gunma University |
|---|
Principal Investigator |
NAKAJIMA Takashi Gunma University, Professor, 医学部, 教授 (20124422)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SANO Takaaki Gunma University, Assistant professor, 医学部, 講師 (90292581)
KASHIWABARA Kenji Yamanashi Medical School, Associate professor, 附属病院, 助教授 (80242634)
OYAMA Tetsunari Gunma University, Associate professor, 医学部, 助教授 (50233622)
|
|---|
| Project Period (FY) |
1999 – 2000
|
| Keywords | Human cancers / Cell cycle regulator proteins / RB pathway / p53 pathway / Immunohistochemistry |
|---|
| Research Abstract |
Expression of cell cycle regulatory proteins in both the RB and p53 pathways were investigated in lung, esophageal and oral cancers using immunohisto-chemical techniques. In squamous cell carcinoma (SCC) of lung, abnormality of p16 expression was prominent at the frequency of 78% in the RB pathway. On the other hand, strong and diffuse p53 immunoreactivity was seen in 60% of SCCs, which seemed to have point mutation of the p53 gene. In comparing clinicopathological status with the immunohistochemical results, strong p53 expression was frequently observed in higher stages of SCC, with the developing tumor located in the central field of the lung. Similarly, the frequency of p14ARF expression was high in centrally developed SCC.
In stage I adenocarcinoma of the lung, abnormality of the RB pathway was not frequent. However, abnormal expression of p14ARF and MDM2 was characteristic features in the p53 pathway. Overexpression of MDM2 protein was characteristic feature in stage I adenocarcinomas, especially in well differentiated ones. These findings elucidate that cell cycle abnormality is mostly depend on p53 pathway other than RB pathway in stage I adenocarcinomas of lung.
The abnormality of both RB and p53 pathways was also observed in esophageal and oral squamous cell carcinomas. Therefore, abnormality in RB and p53 pathways was essential for development of human cancers.
|
Research Products
(13 results)
-
-
-
-
-
-
-
[Publications] Xue, Q., Sano, T., Kashiwabara, K., Oyama, T.and Nakajima, T.: "Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinoma of lung."Jpn.J.Cancer Res.. (March, in press). (2001)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Sano, T., Hikino, T., Xue, Q., Saito, T., Kashiwabara, K., Oyama, T.And Nakajima, T.: "Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma."Pathology Int.. 50. 709-716 (2000)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Kato, H., Yoshikawa, M., Fukai, Y., Tajima, K., Masuda, N., Tsukada, K., Kuwano, H.and Nakajima, T.: "An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers."Anticancer Res.. 20. 345-350 (2000)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Kato, H., Miyazaki, T., Yoshikawa, M., Nakajima, M., Fukai, Y., Tajima, K., Masuda, N., Tsutsumi, S., Tsukada, K., Nakajima, T.and Kuwano, H.: "Nitrotyrosine in esophageal squamous cell carcinoma and relevance to p53 expression."Cancer Letters. 153. 121-127 (2000)
Description
「研究成果報告書概要(欧文)」より
-
-
[Publications] Ishihara, S., Minato, K., Hoshino, H., Saito, R., Hara, F., Nakajima, T.and Mori, M.: "The cyclin-dependent kinase inhibitor p27 as a pprognostic factor in advanced non-small-cell lung cancer : its immunohistochemical evaluation using biopsy specimens.."Lung Cancer. 26. 187-194 (1999)
Description
「研究成果報告書概要(欧文)」より
-
